Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
02/01/2013
Trade Name:
Prezista
Generic Name or Proper Name (*):
darunavir
Indications Studied:
Treatment of HIV-1 infection
Label Changes Summary:
Revised labeling to include once daily dosing in treatment naïve and treatment experienced HIV-1 infected pediatric patients 3 to < 18 years and weighing at least 10 kg Postmarketing study
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Janssen
NNPS:
FALSE'
Therapeutic Category:
Antiviral
-
-